期刊
CIRCULATION
卷 133, 期 21, 页码 2050-2065出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCULATIONAHA.115.021019
关键词
atherosclerosis; cell proliferation; microRNAs; RNA; untranslated; plasma protein; human
资金
- British Heart Foundation [RG/09/005/27915, FS11/12/28673, FS/12/66/30003, PG/12/8/29371, FS/14/78/31020, CH/09/002]
- British Heart Foundation Chair of Translational Cardiovascular Sciences [CH/11/2/28733]
- Wellcome Trust [WT103782AIA]
- NHS Research Scotland (NRS) through NHS Lothian
- British Heart Foundation [RG/14/3/30706, RG/09/005/27915, FS/13/77/30488, PG/12/8/29371, FS/14/78/31020] Funding Source: researchfish
Background Phenotypic switching of vascular smooth muscle cells from a contractile to a synthetic state is implicated in diverse vascular pathologies, including atherogenesis, plaque stabilization, and neointimal hyperplasia. However, very little is known about the role of long noncoding RNA (lncRNA) during this process. Here, we investigated a role for lncRNAs in vascular smooth muscle cell biology and pathology. Methods and Results Using RNA sequencing, we identified >300 lncRNAs whose expression was altered in human saphenous vein vascular smooth muscle cells following stimulation with interleukin-1 and platelet-derived growth factor. We focused on a novel lncRNA (Ensembl: RP11-94A24.1), which we termed smooth muscle-induced lncRNA enhances replication (SMILR). Following stimulation, SMILR expression was increased in both the nucleus and cytoplasm, and was detected in conditioned media. Furthermore, knockdown of SMILR markedly reduced cell proliferation. Mechanistically, we noted that expression of genes proximal to SMILR was also altered by interleukin-1/platelet-derived growth factor treatment, and HAS2 expression was reduced by SMILR knockdown. In human samples, we observed increased expression of SMILR in unstable atherosclerotic plaques and detected increased levels in plasma from patients with high plasma C-reactive protein. Conclusions These results identify SMILR as a driver of vascular smooth muscle cell proliferation and suggest that modulation of SMILR may be a novel therapeutic strategy to reduce vascular pathologies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据